The US Food and Drug Administration's independent Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted Tuesday to support recommending inclusion of an Omicron specific component for a Covid-19 booster vaccine.
The post FDA Advisers Vote To Include An Omicron-Specific Component For A Coronavirus Booster In The US appeared first on The Seattle Medium.
